Medifast, Inc. Equity Securities, FV-NI, Gain (Loss)
Medifast, Inc. (MED) reported Equity Securities, FV-NI, Gain (Loss) of -$4.09 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2025-02-18
- Medifast, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2024-12-31 was -$355.00K, a 336.67% decline year-over-year.
- Medifast, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2024-09-30 was -$1.98M.
- Medifast, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2024-06-30 was -$4.19M.
- Medifast, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2024-03-31 was $2.44M.
- Medifast, Inc. equity securities, fv-ni, gain (loss) for fiscal 2024 was -$4.09M, a 2826.00% decline from fiscal 2023.
- Medifast, Inc. equity securities, fv-ni, gain (loss) for fiscal 2023 was $150.00K.
- Medifast, Inc. equity securities, fv-ni, gain (loss) for fiscal 2022 was $0.00.
- Medifast, Inc. equity securities, fv-ni, gain (loss) for fiscal 2021 was $0.00.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$2.34M derived: sum of 2 quarters · filed 2025-02-18 | -$6.53M derived: sum of 3 quarters · filed 2025-02-18 | -$4.09M 10-K · filed 2025-02-18 |
| 2024-09-30 | -$1.98M 10-Q · filed 2024-11-04 | -$6.17M derived: sum of 2 quarters · filed 2024-11-04 | -$3.73M 10-Q · filed 2024-11-04 | -$3.58M derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-06-30 | -$4.19M 10-Q · filed 2024-08-05 | -$1.75M 10-Q · filed 2024-08-05 | -$1.60M derived: sum of 3 quarters · filed 2025-02-18 | -$1.60M derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-03-31 | $2.44M 10-Q · filed 2024-04-29 | $2.59M derived: sum of 2 quarters · filed 2025-02-18 | $2.59M derived: sum of 3 quarters · filed 2025-02-18 | $2.59M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $150.00K derived: sum of 2 quarters · filed 2025-02-18 | $150.00K derived: sum of 3 quarters · filed 2025-02-18 | $150.00K 10-K · filed 2025-02-18 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-04 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | $0.00 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-05 | $0.00 10-Q · filed 2024-08-05 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-29 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COFFEE HOLDING CO INC (JVA) | United States | $0.023B | 4.10 |